Company Information

CIN
Status
Date of Incorporation
10 December 2003
State / ROC
Delhi / ROC Delhi
Last Balance Sheet
31 March 2022
Last Annual Meeting
30 September 2022
Paid Up Capital
1,600,000
Authorised Capital
2,500,000

Directors

Jhansirani Nadimpalli
Jhansirani Nadimpalli
Director/Designated Partner
almost 3 years ago
Jayapal Garapati
Jayapal Garapati
Director/Designated Partner
about 4 years ago
Venkatasatyasiva Ramakrishnaraju Bhupathiraju
Venkatasatyasiva Ramakrishnaraju Bhupathiraju
Director/Designated Partner
about 5 years ago
Sanjeev Kansal
Sanjeev Kansal
Director
over 16 years ago
Tarun Garg
Tarun Garg
Director
almost 22 years ago
Raj Kumar Mallick
Raj Kumar Mallick
Director
almost 22 years ago

Past Directors

Sarv Mitter Behl
Sarv Mitter Behl
Director
over 21 years ago

Registered Trademarks

Revlicyt Cytogen Pharmaceuticals India

[Class : 5] Medicinal And Pharmaceutical Preparations

Methocyt Cytogen Pharmaceuticals India

[Class : 5] Medicinal And Pharmaceutical Preparations

Tamofyt Cytogen Pharmaceuticals India

[Class : 5] Medicinal And Pharmaceutical Preparations
View +21 more Brands for Cytogen Pharmaceuticals (India) Private Limited.

Documents

Form DPT-3-16122020-signed
Form DIR-12-05122020_signed
Optional Attachment-(3)-05122020
Optional Attachment-(2)-05122020
Optional Attachment-(1)-05122020
Declaration of the appointee director, Managing director, in Form No. DIR-2;-05122020
Declaration by first director-05122020
Form INC-22-19112020_signed
Proof of Registered Office address(Conveyance/Lease deed/Rent Agreement along with the rent receipts) etc-19112020
Copies of the utility bills as mentioned above (not older than two months)-19112020
Optional Attachment-(1)-19112020
Form MGT-7-07112020_signed
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-06112020
List of share holders, debenture holders;-06112020
Directors report as per section 134(3)-06112020
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-06112020
Optional Attachment-(1)-06112020
Form AOC-4-06112020_signed
Optional Attachment-(2)-05112020
Form DIR-11-05112020_signed
Evidence of cessation;-05112020
Notice of resignation;-05112020
Form DIR-12-05112020_signed
Optional Attachment-(3)-05112020
Optional Attachment-(1)-05112020
Optional Attachment-(1)-04112020
Notice of resignation filed with the company-04112020
Proof of dispatch-04112020
Optional Attachment-(2)-04112020
Optional Attachment-(3)-04112020